GWLL · Goldenwell Biotech, Inc.
$0.70
At close · Aug 20
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon, among other things, its ability to generate revenues and its ability to obtain capital from third parties. No assurance can be given that the Company will be successful in these efforts.”View the 10-Q filed Aug 14, 2026
Market Cap
$69.30M
Shares
99.00M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.70
Open$0.70
Day$0.70–0.70
Available close range$0.51–7.00
Avg vol 30d916
Short int16 · 0.0% float · 1.0d
Short vol50%
DataSep 2022–Aug 2026
Filing10-Q · Aug 14
The closing range uses available history since Oct 27, 2025; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
RSI (14)
42
neutral
MACD trend
Negative
52-week position
3%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−69%
trailing
YTD return
−76%
this year
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
−60%
Y/Y
Gross margin
22%
contracting
Quant / Vol
risk profile
Volatility
1690%
annualized · 1-yr
Max drawdown
−93%
past year
ATR
52.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
RSI (14)
42
Neutral
MACD trend
Negative
Bearish
52-week position
3%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its available closing range
Range low $1
Now $1 · 3%
Range high $7
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GWLL
this stock
Goldenwell Biotech, Inc.
|
$69.30M | -75.9% | -60.4% | — | 0.0% |
|
KHC
Kraft Heinz Co
|
$30.48B | +5.9% | -0.1% | — | 7.2% |
|
GIS
General Mills Inc
|
$21.93B | -11.4% | +4.1% | — | 8.4% |
|
MKC
Mccormick & Co Inc
|
$14.88B | -20.4% | +1.7% | 9.2 | 4.9% |
|
JBS
Jbs N.V.
|
$14.55B | -6.8% | — | — | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GWLL | -22.2% | -69.4% | — | -22.2% | -75.9% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -20.3% | -72.7% | — | -24.3% | -87.7% |